AKT1 and cancer: Although further studies are required to increase the resolution for the identification of CIP2A-targeted AKT substrates as well as the role of CIP2A in chemoresistance, based on our preliminary data, we consider CIP2A a promising target for future drug design since it is an effective regulator to restrain cancer cell growth.